Company profile for E-Star Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

E-Star Biotech focuses on developing innovative designer peptides to treat cardiovascular, metabolic, and kidney diseases. Their lead product, MANP, is a novel GC-A receptor activator that pioneers hypertension research. Currently in Phase 2 clinical trials, MANP is being studied for its potential to treat uncontrolled blood pressure and associated metabolic conditions. E-Star Biotech is dedicated to advancing therapeutic opti...
E-Star Biotech focuses on developing innovative designer peptides to treat cardiovascular, metabolic, and kidney diseases. Their lead product, MANP, is a novel GC-A receptor activator that pioneers hypertension research. Currently in Phase 2 clinical trials, MANP is being studied for its potential to treat uncontrolled blood pressure and associated metabolic conditions. E-Star Biotech is dedicated to advancing therapeutic options for major health challenges through scientific innovation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
200 1st Street SW, Rochester
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/03/26/3049650/0/en/E-Star-BioTech-Announces-Presentation-During-2025-Annual-Meeting-of-the-American-College-of-Cardiology.html

GLOBENEWSWIRE
26 Mar 2025

https://www.globenewswire.com/news-release/2025/02/05/3021131/0/en/E-Star-BioTech-Announces-Dosing-of-First-Patient-in-Phase-2-Clinical-Trials-of-MANP-in-Resistant-Hypertension.html

GLOBENEWSWIRE
05 Feb 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty